Biomarkers & Hypersensitivity Pneumonitis Progression
Trial Objectives
.jpg "Image-3269-(1).jpg")
Researchers are studying the blood of hypersensitivity pneumonitis (HP) patients to find out if biomarkers found can predict the progression of the disease. Researchers are particularly interested in understanding if the biomarkers in blood can predict the speed of disease progression.
Who Can Participate
Adults 18 years of age and older.
Age: 18-80 Gender: Any
Estimated Time Commitment
Not Specified
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Elizabeth Del Real
303.398.1172
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Institutes of Health
Principal Investigators
Evans Fernández, MD, MS
Co-Investigators
-
Rebecca C. Keith, MD
-
Michael P. Mohning, MD
-
Joshua J. Solomon, MD
-
Zulma X. Yunt, MD